Dr. Cristian Molina Pizarr | Artificial Intelligence | Innovative Research Award
Hospital Virgen de los Lirios Alcoi Alicante | Spain
Dr. Cristian Antonio Molina Pizarro is a distinguished psychiatrist recognized for his contributions to mental health, suicide prevention, and dual pathology research. Currently serving at Hospital Virgen de los Lirios, he integrates clinical expertise with innovative research to address complex psychiatric conditions. His career spans across Mexico, Spain, Chile, and the United States, where he has worked on pioneering initiatives in early psychosis management, addiction medicine, and artificial intelligence applications in psychiatry. He has served as Subdirector in the Mexican Ministry of Health, where he coordinated national suicide prevention and mental health support brigades. His extensive training in psychiatry, dual pathology, psychosomatics, and emergency mental health care reflects a deep commitment to patient-centered approaches and evidence-based practice. With publications in PubMed and Scopus, advisory roles in major pharmaceutical collaborations, and leadership in international programs, Dr. Molina Pizarro exemplifies innovation, clinical excellence, and global leadership in mental health advancement.
Profile
ORCID
Education
Dr. Molina Pizarro holds a medical degree from the University of Guadalajara, Mexico, and a degree in science from Universidad Federico Santa María, Chile. He specialized in psychiatry at Fundación Jiménez Díaz, Universidad Autónoma de Madrid, where he developed advanced expertise in psychotic disorders and dual pathology. His academic journey includes diverse and highly specialized training: an expert course in schizophrenia and depression from the Spanish Society of Dual Pathology, an emergency diploma in psychiatry from Universidad de Alcalá, and psychosomatics training at Instituto de Estudios Psicosomáticos y Psicoterapia Médica in Madrid. He also completed the University of Virginia Addiction Medicine Fellowship at the Center for Leading Edge Addiction Research. These multidisciplinary studies provided him with a comprehensive perspective on mental health, integrating biological, psychological, and social dimensions. His doctoral studies in medicine at Universidad Autónoma de Madrid further reinforce his academic foundation, preparing him for leadership in research and clinical innovation.
Experience
Dr. Molina Pizarro has extensive experience in clinical psychiatry, research, and public health leadership. He currently practices at Hospital Virgen de los Lirios and CSM La Fábrica Alcoy in Alicante, focusing on first-episode psychosis, relapse prevention, and dual diagnoses. Previously, he worked as a psychiatrist at Fundación Jiménez Díaz, Madrid, where he strengthened his expertise in complex psychiatric cases. As Subdirector in the Mexican Ministry of Health, he coordinated national suicide prevention initiatives, including the “Código 100” program, and led brigades for mental health support in vulnerable communities. His clinical practice emphasizes prevention, early intervention, and treatment adherence, particularly in schizophrenia, bipolar disorder, and substance use disorders. Internationally, he collaborates on digital health projects such as Memind, applying artificial intelligence to mental health detection and follow-up across Spain, USA, Mexico, and Chile. His career reflects a balance between high-level clinical practice, academic teaching, and leadership in national and international mental health programs.
Awards and Honors
Dr. Molina Pizarro has earned recognition for his innovative contributions to psychiatry, particularly in suicide prevention and dual pathology. As a senior speaker and advisory board member for pharmaceutical leaders including Janssen, Otsuka-Lundbeck, Rovi, and Lümbeck, he has influenced mental health strategies across Spain and Mexico. His leadership in the Mexican National Suicide Prevention Programme, “Código 100,” was highly commended for integrating clinical decision-making with human rights, gender equity, and interculturality in mental health services. Accredited as a teacher by the Community of Madrid’s Commission for Continuing Training in Health Professions, he has contributed significantly to psychiatry education and professional development. His published work in the British Medical Journal, PubMed, and Scopus-indexed journals adds further prestige to his profile. His patents in digital health innovation, specifically within AI-assisted psychiatric care, highlight his pioneering role in merging technology with clinical psychiatry. These achievements establish him as a forward-thinking leader in global mental health.
Research Focus
Dr. Molina Pizarro’s research bridges psychiatry, technology, and public health, with a central focus on suicide prevention, artificial intelligence applications, dual pathology, and substance use disorders. He has developed a digital ecosystem for suicide risk detection and management, integrating mobile applications and AI for population-level screening, follow-up, and relapse prevention. His ongoing projects emphasize dynamic models of suicidal risk and the integration of mental health within general health systems to reduce stigma and improve accessibility. His research also extends to first-episode psychosis, emphasizing early detection, treatment adherence, and relapse prevention in young populations. International collaborations, particularly the Memind project across Spain, USA, Mexico, and Chile, highlight his commitment to digital transformation in psychiatry. With publications in BMJ, PubMed, and Scopus, and advisory roles in pharmaceutical innovations, his research not only advances clinical practice but also contributes to systemic mental health reforms and innovative global strategies in psychiatric care.
Publications
Title: The Relation Between Violence and Suicidality in Mexico: The Impact of Different Types of Violence in Suicidal Behaviour Detected by a Massive Mental Health Screening App (MeMind)
Year: 2025
Conclusion
Dr. Cristian Antonio Molina Pizarro is an accomplished psychiatrist whose leadership in suicide prevention, dual pathology, and AI-driven mental health innovation, combined with international collaborations, clinical excellence, and impactful research, make him a strong candidate for the Innovative Research Award.